What is NYMTZ's earnings per share (EPS)?

NYMTZ (NYMTZ) reported diluted earnings per share of $1.10 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

NYMTZ Financials

NYMTZ

FY2025 annual

Revenue $601.9M +50.0% YoY

Net Income $149.0M +340.3% YoY

EPS (Diluted) $1.10 YoY not available

Free Cash Flow $125.9M +1290.3% YoY

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported May 1, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q1 FY2026, filed May 1, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the NYMTZ SEC filings page.

NYMTZ (NYMTZ) reported $601.9M in revenue for fiscal year 2025, up 50.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI NYMTZ FY2025 2026-08-30

Cash-backed rebound meets liability-funded investment expansion in NYMTZ’s asset-heavy 2025 operating model

The FY2025 earnings recovery was largely cash-backed: net income was $149M and operating cash flow was $134M, unlike the prior year’s loss and thin cash generation. Free cash flow reached $126M, indicating that reported profit remained after investment spending rather than existing only through accrual accounting.

Assets expanded from $9.2B in FY2024 to $12.6B in FY2025, while equity stayed near $1.4B; the enlarged asset base was funded predominantly outside equity. That structure leaves total liabilities at 7.9x equity, versus reported debt-to-equity of 0.5x, so the debt ratio alone understates broader reliance on liabilities.

The investment-financing loop paired $2.9B of investing outflows with $2.8B of financing inflows, showing that asset growth relied on external funding rather than internally generated cash. A 1.2% ROA versus 10.5% ROE shows how the thin equity base magnifies returns on a low-yield asset pool.

Financial Health Signals

Financial health score not available

NYMTZ does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

6/7

NYMTZ passes 6 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed

0.90x

For every $1 of reported earnings, NYMTZ generates $0.90 in operating cash flow ($134.0M OCF vs $149.0M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage At Risk

0.30x

NYMTZ earns $0.30 in operating income for every $1 of interest expense ($137.8M vs $452.6M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$172.1M

YoY+32.6%

QoQ+0.8%

5Y CAGR+28.0%

10Y CAGR+7.7%

NYMTZ generated $172.1M in revenue in Q1 2026. This represents an increase of 32.6% from the same quarter a year earlier. Against the prior quarter it is up 0.8%.

EBITDA

$91.3M

YoY+109.5%

QoQ+48.1%

NYMTZ's EBITDA was $91.3M in Q1 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 109.5% from the same quarter a year earlier. Against the prior quarter it is up 48.1%.

Net Income

$48.6M

YoY+15.3%

QoQ-9.2%

5Y CAGR-1.4%

10Y CAGR+11.1%

NYMTZ reported $48.6M in net income in Q1 2026. This represents an increase of 15.3% from the same quarter a year earlier. Against the prior quarter it is down 9.2%.

EPS (Diluted)

$0.40

YoY+21.2%

NYMTZ earned $0.40 per diluted share (EPS) in Q1 2026. This represents an increase of 21.2% from the same quarter a year earlier.

Cash & Balance Sheet

Cash & Debt

$208.9M

YoY+18.0%

QoQ-0.7%

5Y CAGR-6.4%

10Y CAGR+18.0%

NYMTZ held $208.9M in cash against $669.5M in long-term debt as of Q1 2026.

Dividends Per Share

$0.23

YoY+15.0%

QoQ0.0%

5Y CAGR-10.5%

10Y CAGR-0.4%

NYMTZ paid $0.23 per share in dividends in Q1 2026. This represents an increase of 15.0% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

90M

YoY-0.5%

QoQ-0.7%

5Y CAGR-25.0%

10Y CAGR-1.9%

NYMTZ had 90M shares outstanding in Q1 2026. This represents a decrease of 0.5% from the same quarter a year earlier. Against the prior quarter it is down 0.7%.

Free Cash Flow

Not reported for Q1 2026.

Margins & Returns

Operating Margin

50.4%

YoY+21.3pp

QoQ+17.4pp

NYMTZ's operating margin was 50.4% in Q1 2026, reflecting core business profitability. This is up 21.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 17.4 percentage points.

Net Margin

28.2%

YoY-4.2pp

QoQ-3.1pp

10Y change+7.5pp

NYMTZ's net profit margin was 28.2% in Q1 2026, showing the share of revenue converted to profit. This is down 4.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 3.1 percentage points.

Return on Equity

3.3%

YoY+0.3pp

QoQ-0.4pp

5Y change+1.1pp

10Y change+1.4pp

NYMTZ's ROE was 3.3% in Q1 2026, measuring profit generated per dollar of shareholder equity. This is up 0.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.4 percentage points.

Gross Margin

Not reported for Q1 2026.

Capital Allocation

Share Buybacks

$5.0M

NYMTZ spent $5.0M on share buybacks in Q1 2026, returning capital to shareholders by reducing shares outstanding.

R&D Spending

Not reported for Q1 2026.

Capital Expenditures

Not reported for Q1 2026.

NYMTZ Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NYMTZ quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Revenue	$644.3M	$601.9M+50.0%	$401.3M+55.1%	$258.7M+0.1%	$258.4M+24.9%	$206.9M-40.9%	$350.2M-49.6%	$694.6M+52.4%	$455.8M+24.5%	$366.1M+14.7%	$319.3M-5.2%	$336.8M-11.1%	$378.8M+29.9%	$291.7M+112.4%	$137.3M	N/A
SG&A Expenses	$84.7M	$72.7M+49.3%	$48.7M-1.8%	$49.6M-5.5%	$52.4M+7.2%	$48.9M+15.8%	$42.2M+18.0%	$35.8M+28.4%	$27.9M-32.1%	$41.1M+16.6%	$35.2M-10.8%	$39.5M-2.4%	$40.5M+103.1%	$19.9M+74.3%	$11.4M+8.6%	$10.5M
Operating Income	$186.8M	$137.8M+248.3%	-$92.9M-19.5%	-$77.7M+77.1%	-$340.1M-278.1%	$190.9M+166.5%	-$287.3M-266.6%	$172.5M+66.3%	$103.7M+12.9%	$91.9M	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA	N/A	$160.9M+403.1%	-$53.1M0.0%	-$53.1M+75.1%	-$213.3M-201.5%	$210.2M+173.3%	-$286.9M-266.3%	$172.5M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$479.7M	$452.6M+42.6%	$317.4M+65.2%	$192.1M+48.5%	$129.4M+63.2%	$79.3M-64.5%	$223.1M-60.6%	$566.8M+50.3%	$377.1M+22.4%	$308.1M+21.0%	$254.7M+1753.9%	$13.7M+146.7%	$5.6M-16.3%	$6.7M+82.6%	$3.6M-24.6%	$4.8M
Income Tax	-$344K	$145K-86.0%	$1.0M+1281.3%	$75K-86.2%	$542K-77.9%	$2.5M+150.6%	$981K+334.1%	-$419K+60.4%	-$1.1M-131.5%	$3.4M+8.4%	$3.1M-31.8%	$4.5M-29.1%	$6.4M+765.4%	$739K-20.7%	$932K+115.2%	$433K
Net Income	$155.5M	$149.0M+340.3%	-$62.0M-27.5%	-$48.7M+83.7%	-$298.6M-254.6%	$193.2M+167.0%	-$288.5M-266.1%	$173.7M+68.9%	$102.9M+11.9%	$92.0M+36.2%	$67.6M-13.4%	$78.0M-42.7%	$136.2M+97.5%	$69.0M+143.8%	$28.3M+492.1%	$4.8M
EPS (Basic)	N/A	$1.12+198.2%	-$1.14-15.2%	-$0.99+72.6%	-$3.61-337.5%	$1.52+270.8%	-$0.89-236.9%	$0.65+4.8%	$0.62-8.8%	$0.68+36.0%	$0.50-19.4%	$0.62-58.1%	$1.48+33.3%	$1.11+2.8%	$1.08+134.8%	$0.46
EPS (Diluted)	—	$1.10	-$1.14-15.2%	-$0.99	-$3.61	$1.51	-$0.89-239.1%	$0.64	$0.61-7.6%	$0.66+32.0%	$0.50-19.4%	$0.62-58.1%	$1.48+33.3%	$1.11	$1.08	$0.46
Diluted Shares (Avg)	N/A	92M	91M-0.2%	91M	94M	95M	371M+52.9%	243M	147M+13.1%	130M+18.9%	110M+1.1%	108M+23.4%	88M+48.7%	59M	26M	10M

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Revenue	$172.1M+32.6%	$170.7M+44.3%	$160.6M+48.2%	$140.9M+55.2%	$129.7M+54.6%	$118.3M+50.1%	$108.4M+66.2%	$90.8M+57.8%
SG&A Expenses	$24.5M+97.3%	$25.1M+108.7%	$23.3M+95.5%	$11.8M+1.2%	$12.4M-4.9%	$12.0M+2.5%	$11.9M+1.0%	$11.6M-12.5%
Operating Income	$86.7M+130.0%	$56.3M+277.1%	$39.5M-7.7%	$4.3M+118.0%	$37.7M+147.0%	-$31.8M-196.8%	$42.8M+145.6%	-$23.7M+23.0%
EBITDA	$91.3M+109.5%	$61.7M+347.6%	$45.4M-10.8%	$10.2M+188.7%	$43.6M+164.5%	-$24.9M-163.7%	$50.9M+158.0%	-$11.5M+53.4%
Interest Expense	$123.7M+28.0%	$127.5M+39.3%	$124.0M+40.8%	$104.5M+45.6%	$96.6M+46.4%	$91.5M+47.7%	$88.1M+82.1%	$71.7M+69.2%
Income Tax	$159K-75.5%	-$44K+97.1%	-$298K-112.8%	-$161K-147.1%	$648K+683.8%	-$1.5M-1242.9%	$2.3M+4251.8%	$342K+2000.0%
Net Income	$48.6M+15.3%	$53.5M+270.5%	$44.8M+4.6%	$8.5M+154.8%	$42.2M+172.8%	-$31.4M-174.9%	$42.8M+150.7%	-$15.6M+42.1%
EPS (Basic)	$0.41+24.2%	N/A	$0.360.0%	-$0.04+86.2%	$0.33+144.0%	N/A	$0.36+134.6%	-$0.29+29.3%
EPS (Diluted)	$0.40+21.2%	N/A	$0.360.0%	-$0.04+86.2%	$0.33	N/A	$0.36+134.6%	-$0.29+29.3%
Diluted Shares (Avg)	92M+1.1%	N/A	92M+1.1%	90M-0.7%	91M	N/A	91M-0.4%	91M-0.2%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses.

NYMTZ Balance Sheet

NYMTZ quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Total Assets	$12.6B+37.1%	$9.2B+24.5%	$7.4B+18.6%	$6.2B+10.3%	$5.7B+21.5%	$4.7B-80.2%	$23.5B+59.3%	$14.7B+22.2%	$12.1B+34.7%	$9.0B-1.2%	$9.1B-14.1%	$10.5B+6.5%	$9.9B+38.2%	$7.2B+948.8%	$682.7M
Cash & Equivalents	$210.3M+25.6%	$167.4M-10.5%	$187.1M-23.5%	$244.7M-15.5%	$289.6M-1.2%	$293.2M+146.9%	$118.8M+14.5%	$103.7M+9.0%	$95.2M+13.9%	$83.6M+34.9%	$62.0M-18.0%	$75.6M+137.7%	$31.8M+0.1%	$31.8M+91.6%	$16.6M
Goodwill	$22.4M	$0	N/A	N/A	N/A	$0-100.0%	$25.2M0.0%	$25.2M0.0%	$25.2M0.0%	$25.2M	$0	N/A	N/A	N/A	N/A
Total Liabilities	$11.2B+43.6%	$7.8B+35.2%	$5.8B+31.9%	$4.4B+35.6%	$3.2B+37.4%	$2.3B-89.0%	$21.3B+57.0%	$13.6B+22.4%	$11.1B+36.8%	$8.1B-0.9%	$8.2B-15.9%	$9.7B+3.2%	$9.4B+37.7%	$6.8B+1046.6%	$596.4M
Long-Term Debt	$735.8M+28.4%	$573.2M-38.6%	$934.1M+72.2%	$542.5M-45.8%	$1.0B+355.3%	$220.0M-1.6%	$223.6M+4.4%	$214.3M-10.9%	$240.4M	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$1.4B+2.3%	$1.4B-11.7%	$1.6B-10.6%	$1.8B-24.5%	$2.3B+1.7%	$2.3B+4.3%	$2.2B+87.0%	$1.2B+21.4%	$971.9M+14.6%	$848.1M-3.7%	$880.5M+7.7%	$817.9M+70.2%	$480.7M+49.3%	$322.0M+277.6%	$85.3M
Retained Earnings	-$1.4B+1.5%	-$1.4B-14.1%	-$1.3B-19.1%	-$1.1B-88.2%	-$559.3M-1.5%	-$551.3M-270.3%	-$148.9M-44.3%	-$103.2M-36.3%	-$75.7M-21.1%	-$62.5M-439.9%	-$11.6M-135.5%	$32.6M	N/A	-$51.6M+35.4%	-$79.9M

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Total Assets	$12.8B+27.9%	$12.6B+37.1%	$12.4B+39.3%	$10.6B+28.2%	$10.0B+34.3%	$9.2B+24.5%	$8.9B+28.4%	$8.2B+31.1%
Cash & Equivalents	$208.9M+18.0%	$210.3M+25.6%	$185.3M-5.0%	$160.4M-31.9%	$177.1M-22.0%	$167.4M-10.5%	$195.1M-14.6%	$235.5M+1.3%
Goodwill	$22.4M	$22.4M	$22.4M	N/A	N/A	$0	N/A	N/A
Total Liabilities	$11.3B+32.0%	$11.2B+43.6%	$11.0B+47.9%	$9.2B+35.4%	$8.6B+44.8%	$7.8B+35.2%	$7.4B+39.7%	$6.8B+49.5%
Long-Term Debt	$669.5M+2.3%	$735.8M+28.4%	$766.6M+9.6%	$653.0M-18.4%	$654.4M-34.6%	$573.2M-38.6%	$699.4M+28.5%	$800.7M+47.0%
Total Equity	$1.5B+3.9%	$1.4B+2.3%	$1.4B-3.7%	$1.4B-3.5%	$1.4B-5.6%	$1.4B-11.7%	$1.4B-8.3%	$1.4B-15.3%
Retained Earnings	-$1.4B+1.8%	-$1.4B+1.5%	-$1.4B-4.3%	-$1.4B-4.0%	-$1.4B-5.8%	-$1.4B-14.1%	-$1.4B-8.3%	-$1.4B-21.1%

Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Current Liabilities, Non-Current Liabilities.

NYMTZ Cash Flow Statement

NYMTZ quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Operating Cash Flow	$91.5M	$134.0M+852.6%	$14.1M-53.0%	$30.0M-67.4%	$91.8M-33.9%	$138.9M+25.4%	$110.8M+215.5%	$35.1M+45.2%	$24.2M-17.6%	$29.3M-45.5%	$53.8M+48.2%	$36.3M-3.2%	$37.6M-29.6%	$53.3M+83.2%	$29.1M+116.9%	$13.4M
Depreciation & Amortization	N/A	$23.1M-41.9%	$39.8M+61.7%	$24.6M-80.6%	$126.8M+558.8%	$19.3M+4887.0%	$386K	$0	N/A	N/A	N/A	N/A	-$2.7M-119.9%	$13.4M+28.0%	$10.5M+84.5%	$5.7M
Stock-Based Compensation	N/A	$8.2M+35.1%	$6.1M-31.2%	$8.8M-25.8%	$11.9M+16.2%	$10.2M+3.2%	$9.9M+84.9%	$5.4M+107.9%	$2.6M+58.2%	$1.6M+217.5%	$514K-47.7%	$983K-16.7%	$1.2M+31.5%	$897K+8.6%	$826K+293.3%	$210K
Capital Expenditures	N/A	$8.2M-66.9%	$24.6M-51.1%	$50.4M-75.9%	$209.4M+354.6%	$46.1M+22258.7%	$206K+60.9%	$128K-72.0%	$457K+54.4%	$296K	$0	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	$125.9M+1290.3%	-$10.6M+48.3%	-$20.5M+82.6%	-$117.6M-226.6%	$92.9M-16.0%	$110.5M+216.1%	$35.0M+47.4%	$23.7M-18.3%	$29.0M-46.1%	$53.8M	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$2.2B	-$2.9B-29.1%	-$2.2B-84.0%	-$1.2B-139.8%	-$508.8M-282.7%	-$132.9M-106.3%	$2.1B+375.4%	-$769.1M-19.7%	-$642.5M-46.0%	-$439.9M-738.9%	$68.9M-72.5%	$250.5M+300.4%	-$125.0M+17.9%	-$152.3M+85.7%	-$1.1B-1019.1%	-$95.3M
Financing Cash Flow	$2.2B	$2.8B+24.6%	$2.2B+95.6%	$1.1B+147.7%	$460.1M+1578.6%	$27.4M+101.3%	-$2.0B-374.1%	$746.4M+20.2%	$621.2M+64.7%	$377.3M+672.4%	-$65.9M+80.3%	-$333.9M-354.4%	$131.3M+32.6%	$99.0M-90.6%	$1.1B+1230.8%	$79.1M
Dividends Paid	$78.5M	$75.5M+0.7%	$74.9M-41.8%	$128.8M-15.1%	$151.8M+0.1%	$151.6M+43.7%	$105.5M-35.4%	$163.4M+66.8%	$97.9M+4.3%	$93.9M	N/A	N/A	N/A	N/A	$22.3M+169.7%	$8.3M
Share Buybacks	$6.5M	$1.5M-57.0%	$3.5M-59.5%	$8.6M-80.6%	$44.4M	$0	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Operating Cash Flow	-$16.7M-164.7%	$62.1M+113.2%	$6.9M+850.7%	$39.2M+4049.5%	$25.8M+296.6%	$29.1M+122.6%	-$922K-103.2%	-$993K-883.2%
Depreciation & Amortization	$4.6M-21.6%	$5.4M-22.0%	$5.9M-27.0%	$5.9M-51.5%	$5.9M-53.1%	$6.9M+10.1%	$8.1M+31.1%	$12.2M+99.7%
Stock-Based Compensation	$175K-79.7%	N/A	N/A	N/A	$861K	N/A	N/A	N/A
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	$3.5M-38.4%	$7.6M-35.5%	$7.6M-49.0%
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	$25.7M+243.5%	-$8.6M-151.8%	-$8.6M+42.7%
Investing Cash Flow	-$67.0M+91.6%	-$148.1M+74.7%	-$1.6B-91.2%	-$360.0M+37.1%	-$794.2M-212.7%	-$584.3M-47.0%	-$834.1M-10.0%	-$572.1M-371.8%
Financing Cash Flow	$106.7M-85.0%	$130.6M-76.3%	$1.6B+102.6%	$313.5M-43.1%	$713.8M+118.1%	$552.2M+53.6%	$798.8M+8.0%	$550.5M+344.6%
Dividends Paid	$21.4M+16.0%	$20.8M+14.8%	$18.1M-0.2%	$18.2M-0.4%	$18.5M-9.8%	$18.1M-33.4%	$18.1M-33.8%	$18.2M-50.1%
Share Buybacks	$5.0M	$0	$0	$1.5M-57.0%	$0	$0	$0-100.0%	$3.5M

NYMTZ Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NYMTZ quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Operating Margin	22.9%+46.1pp	-23.2%+6.9pp	-30.0%	-131.6%	92.3%+174.3pp	-82.0%-106.9pp	24.8%+2.1pp	22.8%-2.3pp	25.1%	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	24.8%+40.2pp	-15.5%+3.4pp	-18.8%	-115.6%	93.4%+175.8pp	-82.4%-107.4pp	25.0%+2.4pp	22.6%-2.6pp	25.1%+4.0pp	21.2%-2.0pp	23.2%-12.8pp	35.9%+12.3pp	23.6%+3.0pp	20.6%	N/A
Return on Equity	10.4%+14.9pp	-4.5%-1.4pp	-3.1%+13.8pp	-16.9%-25.1pp	8.3%+20.8pp	-12.5%-20.4pp	7.9%-0.8pp	8.7%-0.7pp	9.5%+1.5pp	8.0%-0.9pp	8.9%-7.8pp	16.7%+2.3pp	14.3%+5.6pp	8.8%+3.2pp	5.6%
Return on Assets	1.2%+1.8pp	-0.7%0.0pp	-0.7%+4.1pp	-4.8%-8.2pp	3.4%+9.6pp	-6.2%-6.9pp	0.7%0.0pp	0.7%-0.1pp	0.8%0.0pp	0.8%-0.1pp	0.9%-0.4pp	1.3%+0.6pp	0.7%+0.3pp	0.4%-0.3pp	0.7%
Debt-to-Equity	0.52+0.1x	0.41-0.2x	0.59+0.3x	0.31-0.1x	0.43+0.3x	0.100.0x	0.10-0.1x	0.18-0.1x	0.25-9.3x	9.55+0.3x	9.29-2.6x	11.89-7.7x	19.59-1.6x	21.24+14.2x	6.99
Asset Turnover	0.050.0x	0.040.0x	0.030.0x	0.040.0x	0.040.0x	0.080.0x	0.030.0x	0.030.0x	0.030.0x	0.040.0x	0.040.0x	0.040.0x	0.030.0x	0.02	N/A
FCF Margin	20.9%+23.6pp	-2.6%+5.3pp	-7.9%+37.6pp	-45.5%-90.4pp	44.9%+13.3pp	31.6%+26.5pp	5.0%-0.2pp	5.2%-2.7pp	7.9%-8.9pp	16.9%	N/A	N/A	N/A	N/A	N/A

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Operating Margin	50.4%+21.3pp	33.0%+59.9pp	24.6%-14.9pp	3.0%+29.2pp	29.1%+124.6pp	-26.9%-68.6pp	39.5%	-26.2%+27.4pp
Net Margin	28.2%-4.2pp	31.4%+57.9pp	27.9%-11.6pp	6.1%+23.2pp	32.5%+101.5pp	-26.5%-79.7pp	39.5%	-17.2%+29.6pp
Return on Equity	3.3%+0.3pp	3.8%+6.0pp	3.2%+0.2pp	0.6%+1.7pp	3.0%+6.9pp	-2.3%-4.9pp	3.0%+8.3pp	-1.1%+0.5pp
Return on Assets	0.4%0.0pp	0.4%+0.8pp	0.4%-0.1pp	0.1%+0.3pp	0.4%+1.2pp	-0.3%-0.9pp	0.5%+1.7pp	-0.2%+0.2pp
Debt-to-Equity	0.460.0x	0.52+0.1x	0.55+0.1x	0.47-0.1x	0.47-0.2x	0.41-0.2x	0.48+0.1x	0.56+0.2x
Asset Turnover	0.010.0x	0.010.0x	0.010.0x	0.010.0x	0.010.0x	0.010.0x	0.010.0x	0.010.0x
FCF Margin	N/A	N/A	N/A	N/A	N/A	21.7%+12.2pp	-7.9%-33.3pp	-9.4%+16.5pp

Not reported in any period shown, so not listed: Gross Margin, Current Ratio.

Where NYMTZ Ranks

Frequently Asked Questions

What is NYMTZ's annual revenue?

NYMTZ (NYMTZ) reported $601.9M in total revenue for fiscal year 2025. This represents a 50.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is NYMTZ's revenue growing?

NYMTZ (NYMTZ) revenue grew by 50.0% year-over-year, from $401.3M to $601.9M in fiscal year 2025.

Is NYMTZ profitable?

Yes, NYMTZ (NYMTZ) reported a net income of $149.0M in fiscal year 2025, with a net profit margin of 24.8%.

What is NYMTZ's EBITDA?

NYMTZ (NYMTZ) had EBITDA of $160.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does NYMTZ have?

As of fiscal year 2025, NYMTZ (NYMTZ) had $210.3M in cash and equivalents against $735.8M in long-term debt.

What is NYMTZ's operating margin?

NYMTZ (NYMTZ) had an operating margin of 22.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is NYMTZ's net profit margin?

NYMTZ (NYMTZ) had a net profit margin of 24.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is NYMTZ's return on equity (ROE)?

NYMTZ (NYMTZ) has a return on equity of 10.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is NYMTZ's free cash flow?

NYMTZ (NYMTZ) generated $125.9M in free cash flow during fiscal year 2025. This represents a 1290.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is NYMTZ's operating cash flow?

NYMTZ (NYMTZ) generated $134.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are NYMTZ's total assets?

NYMTZ (NYMTZ) had $12.6B in total assets as of fiscal year 2025, including both current and long-term assets.

What are NYMTZ's capital expenditures?

NYMTZ (NYMTZ) invested $8.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does NYMTZ buy back shares?

Yes, NYMTZ (NYMTZ) spent $1.5M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does NYMTZ have outstanding?

NYMTZ (NYMTZ) had 90M shares outstanding as of fiscal year 2025.

What is NYMTZ's debt-to-equity ratio?

NYMTZ (NYMTZ) had a debt-to-equity ratio of 0.52 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is NYMTZ's return on assets (ROA)?

NYMTZ (NYMTZ) had a return on assets of 1.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is NYMTZ's Piotroski F-Score?

NYMTZ (NYMTZ) has a Piotroski F-Score of 6 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are NYMTZ's earnings high quality?

NYMTZ (NYMTZ) has an earnings quality ratio of 0.90x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can NYMTZ cover its interest payments?

NYMTZ (NYMTZ) has an interest coverage ratio of 0.30x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.